Publicaciones en 2025
de Luque J, Mochón-Jimenez C, Rivera-Ruiz I, Gay-Mimbrera J, Fuentes-Duculan J, Coats I, Aguilar-Luque M, Isla-Tejera B, Nieto AVG, Galán-Gutierrez M, López TLV, Suarez-Fariñas M, Krueger JG, Ruano J. A Functional Genetic Score in the ZMIZ1/TGF-β/STAT Pathway Predicts Early Biologic Discontinuation in Psoriasis Patients Treated with Anti-TNF and Anti-IL12/23 Agents. ADVANCES IN THERAPY. 2025. 6030-6044. DOI:10.1007/s12325-025-03350-0. IF: 4 Q2 D3
Gay-Mimbrera J, Lozano-Ojalvo D, Gómez-Arias PJ, Rivera-Ruiz I, Aguilar-Luque M, Mochón-Jiménez C, Pulido EA, Pérez-Alegre M, Guttman-Yassky E, Ruano J. Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. BRITISH JOURNAL OF DERMATOLOGY. 2025. 115-124. DOI:10.1093/bjd/ljaf041. IF: 9,6 Q1 D1
Gay-Mimbrera J, Gómez-Arias PJ, Alvarez-Heredia P, Batista-Duharte A, Rivera-Ruiz I, Aguilar-Luque M, Juan-Cencerrado M, Mochón-Jiménez C, Cebrián-García A, Andújar-Pulido E, Pérez-Alegre M, Pera A, Ruano J. Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata. FRONTIERS IN IMMUNOLOGY. 2025. -. DOI:10.3389/fimmu.2025.1565241. IF: 5,9 Q1 D2
Rivera-Ruiz I, Gay-Mimbrera J, Gómez-Arias PJ, Aguilar-Luque M, Juan-Cencerrado M, Mochón-Jiménez C, Parra-Peralbo E, Isla-Tejera B, Gómez-García F, Ruano J. Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata. DERMATOLOGY AND THERAPY. 2025. 2729-2748. DOI:10.1007/s13555-025-01471-6. IF: 4,2 Q1 D2
Rivera-Ruiz I, Ungar B, Dávila-Flores V, Gay-Mimbrera J, Gómez-Arias PJ, Juan-Cencerrado M, Mochón-Jiménez C, Parra-Peralbo E, Isla-Tejera B, López TLV, Guttman-Yassky E, Ruano J. Unravelling the transcriptomic landscape of primary lymphocytic scarring alopecias: systematic review and meta-analysis. FRONTIERS IN IMMUNOLOGY. 2025. -. DOI:10.3389/fimmu.2025.1651019. IF: 5,9 Q1 D2
Lluch-Galcerá JJ, Carrascosa JM, González-Quesada A, Sahuquillo-Torralba A, Rivera-Díaz R, Daudén E, Belinchón I, Gómez-García FJ, Herrera-Acosta E, Ruiz-Genao DP, Lopez-Estebaranz JL, Baniandrés-Rodríguez O, Ferrán M, de la Cueva P, Rodríguez L, Mateu A, Riera-Monroig J, Ruiz-Carrascosa JC, Ara-Martín M, Abalde-Pintos MT, Roncero-Riesco M, Pujol-Marco C, García-Donoso C, Llamas-Velasco M, Del Alcázar E, Suárez-Pérez JA, Rodríguez-Sánchez B, Díez-Madueño K, Ruiz-Villaverde R, Lezcano-Biosca V, González-Sixto B, Descalzo MA, García-Doval I. Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025. 1631-1642. DOI:10.1111/jdv.20705. IF: 8 Q1 D1
Ruiz-Villaverde R, Ezomo-Gervilla PJ, Molina-Espinosa J, Galán-Gutierrez M, Herrera-Acosta E, Suarez-Perez JA. Comparative Analysis of Ixekizumab Effectiveness with and Without Induction Therapy in Moderate-to-Severe Psoriasis: A Real-World Study. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14030833. IF: 2,9 Q1 D2
Ruiz-Villaverde R, Ezomo-Gervilla PJ, Molina-Espinosa J, Galán-Gutierrez M, Herrera-Acosta E, Suarez-Perez JA. Comparative Analysis of Ixekizumab Effectiveness with and Without Induction Therapy in Moderate-to-Severe Psoriasis: A Real-World Study. JOURNAL OF CLINICAL MEDICINE. 2025. -. DOI:10.3390/jcm14030833. IF: 2,9 Q1 D2
Liñán-Barroso JM, Hernández-Rodríguez JC, Ruiz-Villaverde R, Gutiérrez MG, Navarro-Triviño F, Cruz JD, Armario-hita JC, Pereyra-rodrigue JJ. Definition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi Consensus. ACTA DERMATO-VENEREOLOGICA. 2025. -. DOI:10.2340/actadv.v105.42240. IF: 3,7 Q1 D2
Rivera-Ruiz I, Gil-Villalba A, Navarro-Triviño FJ. Exploring New Horizons In Allergic Contact Dermatitis Treatment: The Role of Emerging Therapies. ACTAS DERMO-SIFILIOGRAFICAS. 2025. 731-739. DOI:10.1016/j.ad.2024.10.068; 10.1016/j.ad.2024.10.068. IF: 2,8 Q2 D4
Torres EB, Ivars M, Prat C, Vicente A, Rodríguez MF, Pedrero RM, Santiago AM, Giacaman A, Fernández AT, Noguera-Morel L, Mas IB, Gracia LD, Buselli MÉ, Ruiz MP, Wittel JB, García MTM, Domínguez MC, Osuna CG, Jiménez JSJ, Martínez AE, Ninet VZ, Andreu MC, Pérez SIP, Hernández JS, Alom SD, Divasson LF, Cebey AB, Gutiérrez MG, Laguna RD. Real-life retrospective multicentre study to describe the use of dupilumab in paediatric patients with atopic dermatitis in Spain: Patient profile, effectiveness and safety. JEADV CLINICAL PRACTICE. 2025. 416-424. DOI:10.1002/jvc2.565. IF: 0,5 Q4 D
Olivares-Guerrero M, Daudén E, Riera-Monroig J, González-Quesada A, Sahuquillo-Torralba A, Rivera-Díaz R, Carrascosa JM, Belinchón I, Gómez-García FJ, Herrera-Acosta E, Ruiz-Genao DP, Baniandrés-Rodríguez O, Ferrán M, de la Cueva P, Rodríguez L, Mateu A, Ruiz-Carrascosa JC, Ara-Martín M, Abalde-Pintos MT, Roncero-Riesco M, Pujol-Marco C, García-Donoso C, Llamas-Velasco M, Del Alcázar E, Suárez-Pérez J, Rodríguez-Sánchez B, Díez-Madueño K, Ruiz-Villaverde R, Lezcano-Biosca V, González-Sixto B, Descalzo MA, García-Doval I. Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025. 1643-1655. DOI:10.1111/jdv.20738. IF: 8 Q1 D1
Triviño FJN, Amador JPV, Ruiz IR. Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies-A Narrative Review. BIOMEDICINES. 2025. -. DOI:10.3390/biomedicines13102458. IF: 3,9 Q1 D3
Ungar B, Manson M, Kim M, Gour D, Temboonnark P, Metukuru R, Da Rosa JC, Estrada Y, Gay-Mimbrera J, Gómez-Arias PJ, Ruano J, Shemer A, Hanna D, Burnett P, Guttman-Yassky E. Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025. 1277-1287. DOI:10.1016/j.jaad.2025.01.082. IF: 11,8 Q1 D1
Publicaciones en 2024
Salido-Vallejo R, Antoñanzas J, Gómez-Arias P, Aguado L. Double subcutaneous island pedicle flap for reconstruction of large upper and central chin defects. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2024. 727-729. DOI: 10.1111/ddg.15383. IF: 5,5 Q1 D1
Sanz-Cabanillas JL, Gómez-García F, Gómez-Arias PJ, Montilla-López A, Gay-Mimbrera J, Ruano J, Isla-Tejera B, Parra-Peralbo E. Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review. FRONTIERS IN IMMUNOLOGY. 2024. DOI: 10.3389/fimmu.2023.1339337. IF: 5,7 Q1 D3
Gómez-Arias PJ, Gay-Mimbrera J, Rivera-Ruiz I, Aguilar-Luque M, Juan-Cencerrado M, Mochón-Jiménez C, Gómez-García F, Sánchez-González S, Ortega-Hernández A, Gómez-Garre D, Parra-Peralbo E, Isla-Tejera B, Ruano J. Association Between Scalp Microbiota Imbalance, Disease Severity, and Systemic Inflammatory Markers in Alopecia Areata. DERMATOLOGY AND THERAPY. 2024. 2971-2986. DOI: 10.1007/s13555-024-01281-2. IF: 3,5 Q1 D3
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Cebolla-Verdugo M, Prados-Carmona A, Hernández-Montoya C, Armario-Hita JC, Galán-Gutiérrez M. Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain. LIFE-BASEL. 2024. DOI: 10.3390/life14030281. IF: 3,2 Q1 D3
Navarro-Trivino FJ, Salazar-Nievas M, Sanz-Cabanillas JL, Arjona-Aguilera C. Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2024. 260-265. DOI: 10.1111/ajd.14264. IF: 2,2 Q2 D5
Thyssen JP, Silverberg JI, Ruano J, Blauvelt A, Gubelin W, Simpson EL, Weidinger S, Valdez H, Terry KK, Biswas P, Güler E, Feeney C. Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024. 2130-2138. DOI: 10.1111/jdv.20095. IF: 8,4 Q1 D1
Navarro-Triviño FJ, Galán-Gutiérrez M, Hita JCA, Ruiz-Villaverde R, Domínguez-Cruz J, Pereyra-Rodríguez JJ. Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up. DERMATITIS. 2024. S55-S61. DOI: 10.1089/derm.2023.0220. IF: 4 Q1 D2
Lluch-Galcerá JJ, Carrascosa JM, González-Quesada A, Rivera-Díaz R, Sahuquillo-Torralba A, Llamas-Velasco M, Gómez-García F, Herrera-Acosta E, de la Cueva P, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Ferrán M, Mateu A, Rodríguez L, Riera-Monroig J, Abalde-Pintos MT, Carretero G, García-Donoso C, Pujol-Marco C, Del Alcázar E, Santamaría-Domínguez C, Suárez-Pérez JA, Nieto-Benito LM, Ruiz-Genao D, Salgado-Boquete L, Descalzo MA, García-Doval I. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry. BRITISH JOURNAL OF DERMATOLOGY. 2024. 355-363. DOI: 10.1093/bjd/ljad382. IF: 11 Q1 D1
Del Duca E, Dahabreh D, Kim M, Bar J, Da Rosa JC, Rabinowitz G, Facheris P, Arias PJG, Chang AN, Utti V, Chowdhury A, Liu Y, Estrada YD, Laculiceanu A, Agache I, Guttman-Yassky E. Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities. ALLERGY. 2024. 1516-1530. DOI: 10.1111/all.16060. IF: 12,6 Q1 D1
Armario-Hita JC, Pereyra-Rodriguez JJ, González-Quesada A, Herranz P, Suarez R, Galan-Gutiérrez M, Rodríguez-Serna M, de Frutos JO, Carrascosa JM, Serra-Baldrich E, Ara-Martin M, Figueras-Nart I, Silvestre JF, Zaragoza-Ninet V, Ruiz-Villaverde R. Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024. e289-e295. DOI: 10.1111/ijd.17344. IF: 3,5 Q1 D3
Publicaciones en 2023
Galan-Gutierrez M, Font-Ugalde P, Padial E, Hernandez-Montoya C, Godoy D, Armario-Hita JC, Ruiz-Villaverde R. Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2023. 700-706. DOI: 10.1111/ijd.16527. IF: 3,6 Q1 D3
Ruano J, Gay-Mimbrera J, Aguilar-Luque M, Gomez-García F, Parra-Peralbo E, Isla-Tejera B. Evolution of appraisal tool usage preferences in PROSPERO records: a study of non-Cochrane systematic reviews. BMC MEDICAL RESEARCH METHODOLOGY. 2023. DOI: 10.1186/s12874-023-02114-0. IF: 4 Q2 D3
Morelló-Vicente A, Espejo-Marín M, Oteiza-Rius I, Antoñanzas J, Vélez A, Salido-Vallejo R. Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study. CANCERS. 2023. DOI: 10.3390/cancers15205037. IF: 5,2 Q2 D3
Salido-Vallejo R, Escribano-Castillo L, Antoñanzas J, Roldan-Córdoba C, Velez A, Aguado-Gil L. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study. JOURNAL OF CLINICAL MEDICINE. 2023. DOI: 10.3390/jcm12247619. IF: 3,9 Q2 D4
Ruiz-Villaverde R, Galán-Gutiérrez M, Llamas-Velasco M, Salgado-Boquete L, Puig L, de la Cueva P, Carrascosa JM. (Translated article) Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis. ACTAS DERMO-SIFILIOGRAFICAS. 2023. 494-501. DOI: 10.1016/j.ad.2023.02.022. IF: 3,2 Q2 D5
Ruiz-Villaverde R, Galan-Gutierrez M, Llamas-Velasco M, Salgado-Boquete L, Puig L, de la Cueva P, Carrascosa JM, Spanish Psoriasis Grp GPs. [Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis. ACTAS DERMO-SIFILIOGRAFICAS. 2023. 494-501. DOI: 10.1016/j.ad.2023.02.022. IF: 3,2 Q2 D5
Facheris P, Da Rosa JC, Pagan AD, Angelov M, Del Duca E, Rabinowitz G, Arias PJG, Lausell CR, Estrada YD, Bose S, Chowdhury M, Shemer A, Pavel AB, Guttman-Yassky E. Age of onset defines two distinct profiles of atopic dermatitis in adults. ALLERGY. 2023. 2202-2214. DOI: 10.1111/all.15741. IF: 12,4 Q1 D1
Ruiz-Villaverde R, Herrera-Acosta E, de Casas AR, Villegas-Romero IM, Moreno-Suarez FG, Vilchez-Marquez F, Galan-Gutierrez M, Vazquez-Bayo MC, Cases-Merida S, Almazan-Fernandez FM. Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice. JOURNAL OF CLINICAL MEDICINE. 2023. DOI: 10.3390/jcm12175631. IF: 3,9 Q2 D4
Navarro-Trivino F, Alcantara-Luna S, Dominguez-Cruz J, Galan-Gutierrez M, Ruiz-Villaverde R, Pereyra-Rodriguez JJ, Armario-Hita JC. Upadacitinib for moderate to severe atopic dermatitis. IMMUNOTHERAPY. 2023. 799-808. DOI: 10.2217/imt-2023-0037. IF: 2,8 Q4 D
Armario-Hita JC, Galan-Gutierrez M, Dodero-Anillo JM, Carrascosa JM, Ruiz-Villaverde R. Updated Review on Treatment of Atopic Dermatitis. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023. 158-167. DOI: 10.18176/jiaci.0906. IF: 7,2 Q1 D2
Publicaciones en 2022
Gomez-Garcia F, Gomez-Arias PJ, Montilla-Lopez A, Hernandez-Parada J, Sanz-Cabanillas JL, Ruano J, Parra-Peralbo E. FRONTIERS IN MEDICINE. 2022. DOI: 10.3389/fmed.2022.754116
Acosta-Garcia H, Ferrer-Lopez I, Ruano-Ruiz J, Santos-Ramos B, Molina-Lopez T. SYSTEMATIC REVIEWS. 2022. DOI: 10.1186/s13643-022-02161-6
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Chinchay FV, Galan-Gutierrez M. DERMATOLOGIC THERAPY. 2022. DOI: 10.1111/dth.15760
Ruiz-Villaverde R, Chinchay FV, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Galan-Gutierrez M. DERMATOLOGIC THERAPY. 2022. DOI: 10.1111/dth.15835
Guzman-Puche J, Perez-Nadales E, Perez-Vazquez M, Causse M, Gracia-Ahufinger I, Mendez-Natera A, Allalou-Ruiz Y, Elias C, Oteo-Iglesias J, Torre-Cisneros J, Martinez-Martinez L. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022. DOI: 10.1016/j.ijantimicag.2022.106524
Ayen-Rodriguez A, Pereyra-Rodriguez JJ, Navarro-Trivino FJ, Alcantara-Luna S, Dominguez-Cruz J, Galan-Gutierrez M, Vilar-Palomo S, Armario-Hita JC, Ruiz-Villaverde R. LIFE-BASEL. 2022. DOI: 10.3390/life12081159
Benito LMN, Carretero G, Rivera-Diaz R, Carrascosa JM, Dauden E, de la Cueva P, Sahuquillo-Torralba A, Herrera-Acosta E, Baniandres-Rodriguez O, Lopez-Estebaranz JL, Belinchon I, Riera-Monroig J, Ferran M, Gomez-Garcia FJ, Mateu A, Rodriguez L, Vilar-Alejo J, Garcia-Donoso C, Ballesca F, Velasco LM, Botella-Estrada R, Herrera-Ceballos E, Ruiz-Genao DP, Descalzo MA, Garcia-Doval I. ACTAS DERMO-SIFILIOGRAFICAS. 2022. DOI: 10.1016/j.ad.2021.05.027
Dodero-Anillo JM, Lozano-Cuadra IC, Rios-Sanchez E, Pedrosa-Martinez MJ, Ruiz-Carrascosa JC, Galan-Gutierrez M, Armario-Hita JC. LIFE-BASEL. 2022. DOI: 10.3390/life12122075
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Perez-Gil A, Font-Ugalde P, Galan-Gutierrez M. LIFE-BASEL. 2022. DOI: 10.3390/life12111883
Dubin C, Glickman JW, Del Duca E, Chennareddy S, Han J, Dahabreh D, Estrada YD, Zhang N, Kimmel GW, Singer G, Chowdhury M, Zheng AY, Angelov M, Gay-Mimbrera J, Ruiz JR, Krueger JG, Pavel AB, Guttman-Yassky E. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2022. DOI: 10.1016/j.jaad.2021.05.016
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Galan-Gutierrez M. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2022. DOI: 10.1111/ijd.15784
Ruiz-Villaverde R, Vasquez-Chinchay F, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Galan-Gutierrez M. LIFE-BASEL. 2022. DOI: 10.3390/life12091412
Munera-Campos M, Vilar-Alejo J, Rivera R, Carrascosa JM, Dauden E, Herrera-Acosta E, Sahuquillo-Torralba A, Gomez-Garcia FJ, Baniandres-Rodriguez O, de la Cueva P, Lopez-Estebaranz JL, Belinchon I, Ferran M, Riera-Monroig J, Rodriguez L, Carretero G, Garcia-Donoso C, Ballesca F, Llamas-Velasco M, Herrera-Ceballos E, Pujol-Marco C, Nieto-Benito LM, Ruiz-Genao DP, Alsina M, Descalzo MA, Garcia-Doval I. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022. DOI: 10.1080/09546634.2021.1922572
Ruiz-Villaverde R, Fernandez-Freire LR, Font-Ugalde P, Galan-Gutierrez M. JOURNAL OF CLINICAL MEDICINE. 2022. DOI: 10.3390/jcm11175098
Alcantara-Luna S, Ruiz-Villaverde R, Dominguez-Cruz J, Galan-Gutierrez M, Navarro-Trivino F, Pereyra-Rodriguez JJ, Armario-Hita JC. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022. DOI: 10.3390/ijerph191710753
Publications in 2021
Ruiz-Villaverde R, Galan-Gutierrez M. Biosimilars in psoriasis: what should your positioning be?. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021. 21(1):81-86. DOI: 10.1080/14712598.2020.1798924.
IF: 4,388 Q2 D3
Gomez-Arias PJ, Gomez-Garcia F, Hernandez-Parada J, Montilla-Lopez AM, Ruano J, Parra-Peralbo E. Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review. DERMATOLOGY AND THERAPY. 2021. 11(3):733-750. DOI: 10.1007/s13555-021-00517-9.
IF: 3,264 Q2 D5
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Galan-Gutierrez M. Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice. DERMATOLOGIC THERAPY. 2021. 34(2):-. DOI: 10.1111/dth.14798.
IF: 2,851 Q3
Gómez-Arias PJ, Abad-Arenas E, Arias-Blanco MC, Redondo-Sánchez J, Galán-Gutiérrez M , Vélez García-Nieto AJ. Medical and legal aspects of the practice of teledermatology in Spain. Actas Dermo-Sifiliograficas. 2021. 112(2): DOI: 10.1016/j.adengl.2020.09.016. IF: 0,52 Q3 DOI: 10.1016/j.ad.2020.09.003
Hernandez-Fernandez CP, Carretero G, Rivera R, Ferrandiz C, Dauden E, De la Cueva P, Belinchon I, Gomez-Garcia FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferran M, Alsina M, Baniandres-Rodriguez O, Sanchez-Carazo JL, Botella-Estrada R, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, Garcia-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, Lopez-Estebaranz JL, Pujol-Marco C, Descalzo MA, Garcia-Doval I. Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort. ACTA DERMATO-VENEREOLOGICA. 2021. 101():-. DOI: 10.2340/00015555-3711.
IF: 4,437 Q1 D3
He H, Del Duca E, Diaz A, Kim HJ, Gay-Mimbrera J, Zhang N, Wu JN, Beaziz J, Estrada Y, Krueger JG, Pavel AB, Ruano J, Guttman-Yassky E. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021. 147(4):1369-1380. DOI: 10.1016/j.jaci.2020.08.041.
IF: 10,793 Q1 D2
Pereyra-Rodriguez JJ, Alcantara-Luna S, Dominguez-Cruz J, Galan-Gutierrez M, Ruiz-Villaverde R, Vilar-Palomo S, Armario-Hita JC. Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis. LIFE-BASEL. 2021. 11(9):-. DOI: 10.3390/life11090927.
IF: 3,817 Q2 D3
Publicaciones 2021
Ruiz-Villaverde R, Galan-Gutierrez M. Biosimilars in psoriasis: what should your positioning be?. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021. 21(1):81-86. DOI: 10.1080/14712598.2020.1798924.
IF: 4,388 Q2 D3
Gomez-Arias PJ, Gomez-Garcia F, Hernandez-Parada J, Montilla-Lopez AM, Ruano J, Parra-Peralbo E. Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review. DERMATOLOGY AND THERAPY. 2021. 11(3):733-750. DOI: 10.1007/s13555-021-00517-9.
IF: 3,264 Q2 D5
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Armario-Hita JC, Perez-Gil A, Galan-Gutierrez M. Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice. DERMATOLOGIC THERAPY. 2021. 34(2):-. DOI: 10.1111/dth.14798.
IF: 2,851 Q3
Gómez-Arias PJ, Abad-Arenas E, Arias-Blanco MC, Redondo-Sánchez J, Galán-Gutiérrez M , Vélez García-Nieto AJ. Medical and legal aspects of the practice of teledermatology in Spain. Actas Dermo-Sifiliograficas. 2021. 112(2): DOI: 10.1016/j.adengl.2020.09.016. IF: 0,52 Q3 DOI: 10.1016/j.ad.2020.09.003
Hernandez-Fernandez CP, Carretero G, Rivera R, Ferrandiz C, Dauden E, De la Cueva P, Belinchon I, Gomez-Garcia FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferran M, Alsina M, Baniandres-Rodriguez O, Sanchez-Carazo JL, Botella-Estrada R, Sahuquillo-Torralba A, Rodriguez L, Vilar-Alejo J, Garcia-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, Lopez-Estebaranz JL, Pujol-Marco C, Descalzo MA, Garcia-Doval I. Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort. ACTA DERMATO-VENEREOLOGICA. 2021. 101():-. DOI: 10.2340/00015555-3711.
IF: 4,437 Q1 D3
He H, Del Duca E, Diaz A, Kim HJ, Gay-Mimbrera J, Zhang N, Wu JN, Beaziz J, Estrada Y, Krueger JG, Pavel AB, Ruano J, Guttman-Yassky E. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2021. 147(4):1369-1380. DOI: 10.1016/j.jaci.2020.08.041.
IF: 10,793 Q1 D2
Pereyra-Rodriguez JJ, Alcantara-Luna S, Dominguez-Cruz J, Galan-Gutierrez M, Ruiz-Villaverde R, Vilar-Palomo S, Armario-Hita JC. Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis. LIFE-BASEL. 2021. 11(9):-. DOI: 10.3390/life11090927.
IF: 3,817 Q2 D3
Publicaciones 2020
Galan-Gutierrez M, Gomez-Arias PJ, Rodenas-Herranz T, Ruiz-Villaverde R. Autoimmune progesterone dermatitis: Successful outcome with bilateral salpingo-oophorectomy. DERMATOLOGIC THERAPY. 2020. 33 (4):- DOI: 10.1111/dth.13520
IF: 2,327 Q: 2
Ruiz-Villaverde R, Galan-Gutierrez M. Biosimilars in psoriasis: what should your positioning be?. EXPERT OPINION ON BIOLOGICAL THERAPY. 2021. 21 (1):81-86 DOI: 10.1080/14712598.2020.1798924
IF: 3,224 Q: 2
Arias PJG, Romero JLH, Cabanillas JLS, Gomez BB, Garcia-Nieto AJV. Bullous Erythema Elevatum Diutinum Associated with Immunoglobulin a Monoclonal Gammopathy: An Atypical Variant. INDIAN JOURNAL OF DERMATOLOGY. 2020. 65 (2):164-165 DOI: 10.4103/ijd.IJD_380_18
IF: 1,523 Q: 3
Salido-Vallejo R, Jimenez-Najar F, Garnacho-Sucedo G, Velez A. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach. ARCHIVES OF DERMATOLOGICAL RESEARCH. 2020. 312 (9):675-680 DOI: 10.1007/s00403-019-02028-2
IF: 2,339 Q: 2
Martinez-Jimenez MD, Gomez-Garcia FJ, Gil-Campos M, Perez-Navero JL. Comorbidities in childhood associated with extrauterine growth restriction in preterm infants: a scoping review. EUROPEAN JOURNAL OF PEDIATRICS. 2020. 179 (8):1255-1265 DOI: 10.1007/s00431-020-03613-8
IF: 2,305 Q: 2
Del Duca E, Ruiz JR, Pavel AB, Sanyal RD, Song T, Gay-Mimbrera J, Zhang N, Estrada YD, Peng X, Renert-Yuval Y, Phelps RG, Paus R, Krueger JG, Guttman-Yassky E. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing. BRITISH JOURNAL OF DERMATOLOGY. 2020. 183 (6):1083-1093 DOI: 10.1111/bjd.19040
IF: 7 Q: 1 D: 1
Min MS, Wu JN, He H, Sanz-Cabanillas JL, Del Duca E, Zhang N, Renert-Yuval Y, Pavel AB, Lebwohl M, Guttman-Yassky E. Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2020. 83 (1):63-70 DOI: 10.1016/j.jaad.2019.12.028
IF: 8,277 Q: 1 D: 1
Rombey T, Puljak L, Allers K, Ruano J, Pieper D. Inconsistent views among systematic review authors toward publishing protocols as peer -reviewed articles: an international survey. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2020. 123 ():9-17 DOI: 10.1016/j.jclinepi.2020.03.010
IF: 4,952 Q: 1 D: 1
Dauden E, Carretero G, Rivera R, Ferrandiz C, Llamas-Velasco M, de la Cueva P, Belinchon I, Gomez-Garcia FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferran-Farres M, Alsina M, Baniandres-Rodriguez O, Sanchez-Carazo JL, Sahuquillo-Torralba A, Fernandez-Freire LR,. Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2020. 83 (1):139-150 DOI: 10.1016/j.jaad.2020.03.033
IF: 8,277 Q: 1 D: 1
Gomez-Arias PJ, Garcia-Nieto AJV. Rupioid psoriasis on the hands. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2020. 192 (45):E1407-E1407 DOI: 10.1503/cmaj.200517
IF: 7,744 Q: 1 D: 1
He HL, Suryawanshi H, Morozov P, Gay-Mimbrera J, Del Duca E, Kim HJ, Kameyama N, Estrada Y, Der E, Krueger JG, Ruano J, Tuschl T, Guttman-Yassky E. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020. 145 (6):1615-1628 DOI: 10.1016/j.jaci.2020.01.042
IF: 10,228 Q: 1 D: 1
Conde C, Escribano BM, Luque E, Aguilar-Luque M, Feijoo M, Ochoa JJ, LaTorre M, Giraldo AI, Lillo R, Aguera E, Santamaria A, Tunez I. The protective effect of extra-virgin olive oil in the experimental model of multiple sclerosis in the rat. NUTRITIONAL NEUROSCIENCE. 2020. 23 (1):37-48 DOI: 10.1080/1028415X.2018.1469281
IF: 4,028 Q: 2
Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrandiz C, Dauden-Tello E, de la Cueva P, Gomez-Garcia FJ, Belinchon I, Herrera-Acosta E, Ruiz-Genao D, Ferran M, Alsina M, Sanchez-Carazo JL, Baniandres O, Fernandez-Freire LR, Vilar J, Garcia-Donoso C, Car. The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2020. 82 (3):738-741 DOI: 10.1016/j.jaad.2019.07.028
IF: 8,277 Q: 1 D: 1
Ruano J, Gomez-Garcia F, Pieper D, Puljak L. What evidence-based medicine researchers can do to help clinicians fighting COVID-19?. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2020. 124 ():183-185 DOI: 10.1016/j.jclinepi.2020.04.015
IF: 4,952 Q: 1 D: 1
Publicaciones 2019
Zhou LS, Leonard A, Pavel AB, Malik K, Raja A, Glickman J, Estrada YD, Peng XY, del Duca E, Sanz-Cabanillas J, Ruano J, Xu H, Zhang N, Wen HC, Gonzalez J, Garcet S, Krueger JG, Guttman-Yassky E; Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019 Jul;144(1):144-156. doi: 10.1016/j.jaci.2019.01.015.
IF: 14,11 D: 1
Barbarroja N, Arias-de la Rosa I, Lopez-Medina C, Camacho-Sanchez MD, Gomez-Garcia I, Velez-Garcia AJ, Escudero-Contreras A, Lopez-Pedrera C, Lopez-Montilla MD, Collantes-Estevez E; Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2019 Oct 16;11:1759720X19880742. doi: 10.1177/1759720X19880742.
IF: 5,045 Q: 1 D: 2
Montilla AM, Gomez-Garcia F, Gomez-Arias PJ, Gay-Mimbrera J, Hernandez-Parada J, Isla-Tejera B, Ruano J; Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata. DERMATOLOGY AND THERAPY. 2019 Dec;9(4):655-683. doi: 10.1007/s13555-019-00329-y.
IF: 3,615 Q: 1 D: 2
Alcantara-Reifs CM, Salido-Vallejo R, Garnacho-Saucedo GM, Garcia-Nieto AV; Dome-shaped nodules and scaly, verruciform plaques on the legs and feet. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY. 2019 Mar-Apr;85(2):226-228. doi: 10.4103/ijdvl.IJDVL_255_17.
IF: 3,03 Q: 2
Viguera-Guerra I, Ruano J, Aguilar-Luque M, Gay-Mimbrera J, Montilla A, Fernandez-Rueda JL, Fernandez-Chaichio J, Sanz-Cabanillas JL, Gomez-Arias PJ, Garcia-Nieto AV, Gomez-Garcia F, Isla-Tejera B; Evolution of international collaborative research efforts to develop non-Cochrane systematic reviews. PLOS ONE. 2019 Feb 27;14(2):e0211919. doi: 10.1371/journal.pone.0211919.
IF: 2,776 Q: 2
Gomez-Garcia F, Gomez-Arias PJ, Hernandez J, Montilla AM, Gay-Mimbrera J, Aguilar-Luque M, Viguera-Guerra I, Garcia-Nieto AV, Isla-Tejera B, Ruano J; Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review. BMJ OPEN. 2019 May 22;9(5):e028303. doi: 10.1136/bmjopen-2018-028303.
IF: 2,413 Q: 2
Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, Castellanos-Gonzalez M, Fernandez-Pugnaire MA, Grimalt R, Hermosa-Gelbard A, Bernardez C, Molina-Ruiz AM, Ormaechea-Perez N, Fernandez-Crehuet P, Vano-Galvan S; Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2019 Jun;44(4):404-410. doi: 10.1111/ced.13785.
IF: 1,771 Q: 3
Publicaciones 2018
Ruano J, Gomez-Garcia F, Gay-Mimbrera J, Aguilar-Luque M, Fernandez-Rueda JL, Fernandez-Chaichio J, Alcalde-Mellado P, Carmona-Fernandez PJ, Sanz-Cabanillas JL, Viguera-Guerra I, Franco-Garcia F, Cardenas-Aranzana M, Romero JLH, Gonzalez-Padilla M, Isla-Tejera B, Garcia-Nieto AV. Evaluating characteristics of PROSPERO records as predictors of eventual publication of non-Cochrane systematic reviews: a meta-epidemiological study protocol. SYSTEMATIC REVIEWS. 2018; 7: Núm artículo 43
IF: 6,754 Q: 1 D: 1
Ruano J, Aguilar-Luque M, Isla-Tejera B, Alcalde-Mellado P, Gay-Mimbrera J, Hernandez-Romero JL, Sanz-Cabanillas JL, Maestre-Lopez B, Gonzalez-Padilla M, Carmona-Fernandez PJ, Gomez-Garcia F, Garcia-Nieto AV. Relationships between abstract features and methodological quality explained variations of social media activity derived from systematic reviews about psoriasis interventions. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2018; 101:35-43.
IF: 4,245 Q: 1
Gomez-Garcia F, Sanz-Cabanillas JL, Viguera-Guerra I, Isla-Tejera B, Nieto AVG, Ruano J. Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA. DERMATOLOGY AND THERAPY. 2018; 8(4):539-556.
IF: 3,620 Q: 1
Gomez-Garcia F, Ruano J, Gay-Mimbrera J, Aguilar-Luque M, Sanz-Cabanillas JL, Romero JLH, Garcia-Nieto AV. A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety. DERMATOLOGY AND THERAPY. 2018; 8(2):195-202.
IF: 3,620 Q: 1
Ruano J, Aguilar-Luque M, Gomez-Garcia F, Mellado PA, Gay-Mimbrera J, Carmona-Fernandez PJ, Maestre-Lopez B, Sanz-Cabanillas JL, Romero JLH, Gonzalez-Padilla M, Garcia-Nieto AV, Isla-Tejera B. The differential impact of scientific quality, bibliometric factors, and social media activity on the influence of systematic reviews and meta-analyses about psoriasis. PLOS ONE. 2018; 13(1): Núm artículo e0191124
IF: 2,766 Q: 1
Gonzalez-Cantero A, Carretero G, Rivera R, Ferrandiz C, Dauden E, de la Cueva P, Gomez-Garcia FJ, Belinchon I, Herrera-Ceballos E, Ruiz-Genao D, Ferran M, Alsina M, Sanchez-Carazo JL, Baniandres O, Sahuquillo-Torralba A, Rodriguez L, Vilar J, Garcia C, Carrascosa JM, Llamas-Velasco M, Herrera-Acosta E, Lopez-Estebaranz JL, Botella-Estrada R, Descalzo MA, Garcia-Doval I; Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population. BRITISH JOURNAL OF DERMATOLOGY. 2019 Nov;181(5):1085-1087. doi: 10.1111/bjd.18164.
IF: 6,714 D:1 Q:1
Descalzo MA, Carretero G, Ferrandiz C, Rivera R, Dauden E, Gomez-Garcia FJ, de la Cueva P, Herrera-Ceballos E, Belinchon I, Lopez-Estebaranz JL, Alsina M, Sanchez-Carazo JL, Ferran M, Baniandres O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Munoz-Santos C, Garcia-Doval I. Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2018; 78(4):798-800.
IF: 6,898 Q: 1 D: 1
Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gomez-Garcia FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern RS, Naldi L. Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the UK and Republic of Ireland. BRITISH JOURNAL OF DERMATOLOGY. 2018; 179(4):863-871.
IF: 6,129 Q: 1 D: 1
Escribano BM, Aguera E, Aguilar-Luque M, Luque E, Feijoo M, LaTorre M, Giraldo AI, Galvan-Jurado A, Caballero-Villarraso J, Garcia-Maceira FI, Santamaria A, Tunez I. Neuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: Antioxidant effects. JOURNAL OF FUNCTIONAL FOODS. 2018; 42:281-288.
IF: 3,47 Q: 1
Hernandez GC, Ferrandiz C, Diaz RR, Tello ED, de la Cueva-Dobao P, Gomez-Garcia FJ, Herrera-Ceballos E, Romero IB, Lopez-Estebaranz JL, Gibert MA, Sanchez-Carazo JL, Farres MF, Quesada AG, Carrillo JMC, Llamas-Velasco M, Fernandez MVM, Genao DR, Santos CM, Garcia-Doval I, Descalzo MA. Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Betwswn 2008 and 2016. ACTAS DERMO-SIFILIOGRAFICAS. 2018; 109(7):617-623.
